Keio University' s Dr. Suda Selects Fluidigm Corporation BioMark(TM) System for Single Stem Cell Research
SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--Fluidigm Corporation today announced that Dr. Toshio Suda of Keio University’s 21st Century Center of Excellence (COE) Program, Graduate School of Medicine, has selected the BioMark™ System for Genetic Analysis to assist their research of mouse hematopoietic single stem cells.